NASDAQ · Medical - Devices
TCMD (TCMD) Stock
$27.55
-0.67%
NASDAQ: TCMD
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
GlobeNewswire · Jul 21, 2026
Tactile Systems Technology Expands Compression Therapy Portfolio With ElastiMed Distribution Deal
MT Newswires · Jul 13, 2026
Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
GlobeNewswire · Jul 13, 2026
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
Zacks · Jun 29, 2026
Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy
GlobeNewswire · Jun 2, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held2.31%
Institutions Held103.10%
Institutions Float Held105.54%
Peer Comparison
About TCMD
TCMD is led by CEO Sheri Louise Dodd, employs 1,037 people, headquartered in US, publicly traded since 2016.
TCMD stock trades at $27.55 with a market capitalization of $621.54M. The stock is valued at a price-to-earnings (P/E) ratio of 29.59, price-to-book of 2.50, price-to-sales of 1.58. Over the past 52 weeks the stock has ranged between $9.41 and $37.77, and currently trades 27.1% below its 52-week high.
On profitability, TCMD generates a return on equity (ROE) of 8.68%, return on capital employed of 13.24%, an operating margin of 8.79%, a net profit margin of 5.91%.